Ultralife (NASDAQ:ULBI – Get Free Report) is scheduled to release its earnings data before the market opens on Friday, November 8th. Investors that wish to register for the company’s conference call can do so using this link.
Ultralife Price Performance
NASDAQ ULBI opened at $9.48 on Thursday. The business’s fifty day moving average is $9.25 and its 200 day moving average is $10.35. Ultralife has a fifty-two week low of $6.36 and a fifty-two week high of $13.39. The company has a debt-to-equity ratio of 0.07, a quick ratio of 2.06 and a current ratio of 4.07. The company has a market capitalization of $157.56 million, a PE ratio of 15.54 and a beta of 0.98.
Analyst Ratings Changes
Separately, StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Read More
- Five stocks we like better than Ultralife
- What is a Low P/E Ratio and What Does it Tell Investors?
- What a Trump Win Looks Like for the Market Now and Into 2025
- Using the MarketBeat Dividend Yield Calculator
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.